BRPI1013358A2 - ap2 secretada e métodos para inibir a mesma. - Google Patents
ap2 secretada e métodos para inibir a mesma.Info
- Publication number
- BRPI1013358A2 BRPI1013358A2 BRPI1013358A BRPI1013358A BRPI1013358A2 BR PI1013358 A2 BRPI1013358 A2 BR PI1013358A2 BR PI1013358 A BRPI1013358 A BR PI1013358A BR PI1013358 A BRPI1013358 A BR PI1013358A BR PI1013358 A2 BRPI1013358 A2 BR PI1013358A2
- Authority
- BR
- Brazil
- Prior art keywords
- secretion
- inhibit
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Emergency Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Zoology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20925109P | 2009-03-05 | 2009-03-05 | |
| US29917010P | 2010-01-28 | 2010-01-28 | |
| PCT/US2010/026305 WO2010102171A2 (en) | 2009-03-05 | 2010-03-05 | Secreted ap2 and methods of inhibiting same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1013358A2 true BRPI1013358A2 (pt) | 2016-03-29 |
Family
ID=42312973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1013358A BRPI1013358A2 (pt) | 2009-03-05 | 2010-03-05 | ap2 secretada e métodos para inibir a mesma. |
Country Status (16)
| Country | Link |
|---|---|
| US (5) | US20120134998A1 (pt) |
| EP (2) | EP2403605B1 (pt) |
| JP (4) | JP5984396B2 (pt) |
| CN (3) | CN107149679B (pt) |
| AU (2) | AU2010221182B2 (pt) |
| BR (1) | BRPI1013358A2 (pt) |
| CA (1) | CA2753991C (pt) |
| DK (1) | DK2403605T3 (pt) |
| ES (1) | ES2542737T3 (pt) |
| HK (1) | HK1212923A1 (pt) |
| HR (1) | HRP20150807T1 (pt) |
| PL (1) | PL2403605T3 (pt) |
| PT (1) | PT2403605E (pt) |
| SI (1) | SI2403605T1 (pt) |
| SM (1) | SMT201500190B (pt) |
| WO (1) | WO2010102171A2 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2403605T3 (pl) | 2009-03-05 | 2016-01-29 | Harvard College | Kompozycje zawierające przeciwciało specyficzne względem aP2 albo jego fragment do zastosowania w leczeniu cukrzycy, nietolerancji glukozy lub insulinooporności wywołanej otyłością |
| CN103665139A (zh) * | 2013-11-29 | 2014-03-26 | 中国药科大学 | 一种脂肪细胞型脂肪酸结合蛋白及其单克隆抗体的制备和应用 |
| JP6223376B2 (ja) | 2014-03-24 | 2017-11-01 | 花王株式会社 | Ｇｉｐ上昇抑制剤の評価又は選択方法 |
| TW201702271A (zh) | 2015-04-30 | 2017-01-16 | 哈佛大學校長及研究員協會 | 治療代謝病症之抗－ａｐ２抗體及抗原結合劑 |
| AU2016276942B2 (en) | 2015-06-10 | 2022-08-25 | Children's National Medical Center | Adipocyte-derived exosomes, and compositions, kits, and methods of using the same for detection and screening |
| JP6558729B2 (ja) * | 2015-06-15 | 2019-08-14 | 北海道公立大学法人 札幌医科大学 | 糸球体障害の検査方法 |
| EP3475299A4 (en) * | 2016-06-27 | 2020-03-18 | President and Fellows of Harvard College | COMPOUNDS USEFUL FOR TREATING METABOLIC DISORDERS |
| US10792119B2 (en) | 2017-05-22 | 2020-10-06 | Ethicon Llc | Robotic arm cart and uses therefor |
| US10856948B2 (en) | 2017-05-31 | 2020-12-08 | Verb Surgical Inc. | Cart for robotic arms and method and apparatus for registering cart to surgical table |
| CA3066733A1 (en) | 2017-06-09 | 2018-12-13 | President And Fellows Of Harvard College | Method to identify compounds useful to treat dysregulated lipogenesis, diabetes, and related disorders |
| US10913145B2 (en) | 2017-06-20 | 2021-02-09 | Verb Surgical Inc. | Cart for robotic arms and method and apparatus for cartridge or magazine loading of arms |
| CN109971761B (zh) * | 2019-04-12 | 2022-07-29 | 宁夏大学 | 脂肪酸结合蛋白4的小干扰rna及其应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK4360C (da) | 1901-11-18 | Bethlehem Steel Corp | Anordning til Regulering af Temperaturen i et Metalbad til Brug ved Hærdning. | |
| DK1507C (da) | 1898-03-21 | Peter Holger Hansen | Fremgangsmaade til Fremstilling af en hornagtig Masse af Kasein. | |
| DE69130741T2 (de) * | 1990-05-16 | 1999-07-29 | Dana Farber Cancer Inst Inc | Immunogene peptide, antikörper sowie deren verwendungen im zusammenhang mit der cd4-rezeptorbindung |
| US5889167A (en) | 1996-05-22 | 1999-03-30 | Merck & Co., Inc. | Synthetic glucagon binding proteins |
| CA2344300A1 (en) * | 1998-09-17 | 2000-03-23 | Jeffrey A. Robl | Method for treating atherosclerosis employing an ap2 inhibitor and combination |
| DE60041246D1 (de) * | 1999-02-12 | 2009-02-12 | Harvard College | Hemmung der bildung von atherosklerotischen wunden mittels afabp antisens nukleinsäuren |
| US6548529B1 (en) * | 1999-04-05 | 2003-04-15 | Bristol-Myers Squibb Company | Heterocyclic containing biphenyl aP2 inhibitors and method |
| US7390824B1 (en) * | 1999-09-07 | 2008-06-24 | Bristol-Myers Squibb Company | Method for treating diabetes employing an aP2 inhibitor and combination |
| WO2002098917A2 (en) * | 2001-02-12 | 2002-12-12 | Curagen Corporation | Human proteins and nucleic acids encoding same |
| US6919323B2 (en) * | 2001-07-13 | 2005-07-19 | Bristol-Myers Squibb Company | Pyridazinone inhibitors of fatty acid binding protein and method |
| AU2002348276A1 (en) * | 2001-11-16 | 2003-06-10 | Bristol-Myers Squibb Company | Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein |
| TW200518768A (en) * | 2003-11-17 | 2005-06-16 | Pepgen Corp | Methods for treatment of obesity and for promotion of weight loss |
| DE102006034607A1 (de) * | 2005-07-21 | 2007-01-25 | Biovendor Laboratory Medicine, Inc. | Verfahren zur Bestimmung der Konzentration der adipozytären Form des fatty acid binding protein (A-FABP, FABP4, P2) |
| ATE468128T1 (de) * | 2005-07-21 | 2010-06-15 | Biovendor Lab Medicine Inc | Verfahren zur bestimmung der konzentration der adipozytaren form des fatty acid bindung protein (a-fabp, fabp4, ap2) |
| ES2651503T3 (es) | 2008-11-20 | 2018-01-26 | Mesoblast, Inc. | Método para tratar o prevenir una disfunción pancreática |
| PL2403605T3 (pl) | 2009-03-05 | 2016-01-29 | Harvard College | Kompozycje zawierające przeciwciało specyficzne względem aP2 albo jego fragment do zastosowania w leczeniu cukrzycy, nietolerancji glukozy lub insulinooporności wywołanej otyłością |
-
2010
- 2010-03-05 PL PL10707783T patent/PL2403605T3/pl unknown
- 2010-03-05 ES ES10707783.6T patent/ES2542737T3/es active Active
- 2010-03-05 EP EP10707783.6A patent/EP2403605B1/en active Active
- 2010-03-05 CN CN201710076996.8A patent/CN107149679B/zh active Active
- 2010-03-05 CN CN2010800198008A patent/CN102639149A/zh active Pending
- 2010-03-05 JP JP2011553125A patent/JP5984396B2/ja active Active
- 2010-03-05 BR BRPI1013358A patent/BRPI1013358A2/pt not_active Application Discontinuation
- 2010-03-05 US US13/203,880 patent/US20120134998A1/en not_active Abandoned
- 2010-03-05 PT PT107077836T patent/PT2403605E/pt unknown
- 2010-03-05 AU AU2010221182A patent/AU2010221182B2/en active Active
- 2010-03-05 CN CN201710076983.0A patent/CN107141353A/zh active Pending
- 2010-03-05 SI SI201030995T patent/SI2403605T1/sl unknown
- 2010-03-05 CA CA2753991A patent/CA2753991C/en active Active
- 2010-03-05 WO PCT/US2010/026305 patent/WO2010102171A2/en active Application Filing
- 2010-03-05 DK DK10707783.6T patent/DK2403605T3/en active
- 2010-03-05 EP EP15154201.6A patent/EP2898898A1/en active Pending
-
2015
- 2015-03-20 JP JP2015057399A patent/JP5966039B2/ja active Active
- 2015-07-23 HR HRP20150807TT patent/HRP20150807T1/hr unknown
- 2015-08-06 SM SM201500190T patent/SMT201500190B/xx unknown
-
2016
- 2016-01-29 HK HK16101022.2A patent/HK1212923A1/zh unknown
- 2016-04-07 JP JP2016076997A patent/JP6301995B2/ja active Active
- 2016-04-07 US US15/093,508 patent/US9879078B2/en active Active
- 2016-07-04 JP JP2016132195A patent/JP2016180000A/ja active Pending
- 2016-10-27 AU AU2016250423A patent/AU2016250423A1/en not_active Abandoned
-
2017
- 2017-12-21 US US15/851,040 patent/US10882901B2/en active Active
-
2020
- 2020-11-23 US US17/102,329 patent/US11685774B2/en active Active
-
2023
- 2023-06-26 US US18/341,404 patent/US20240209072A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1013358A2 (pt) | ap2 secretada e métodos para inibir a mesma. | |
| BR112012004807A2 (pt) | vacina para pcsk9 | |
| BRPI1007856A2 (pt) | braçadeira para cabos | |
| BRPI1014721A2 (pt) | métodos e dispositivos para cortar e raspar tecido | |
| BR112012014032A2 (pt) | dispositivo para aparar cabelo | |
| BR112012002269A2 (pt) | implemento para tratar superfície | |
| BRPI1015147A2 (pt) | métodos para melhorar a farmacocinética | |
| FR2946492B3 (fr) | Coupe-herbe | |
| IT1395844B1 (it) | Tagliaerba | |
| BRPI0917655A2 (pt) | Sobremesa composta e processamento para preparar a mesma. | |
| BRPI1015535A2 (pt) | coquilha para lingotamento contínuo | |
| IT1398233B1 (it) | Tostapane | |
| DK2206486T3 (da) | Sengehest | |
| BR112012010444A2 (pt) | dispositivo para movimento lateral | |
| BRPI1015033A2 (pt) | máquina para fundição contínua | |
| ES1071127Y (es) | Plomo para pesca mejorado | |
| BR112012000180A2 (pt) | microbicidas | |
| ES1070148Y (es) | Macolla para barrotes mejorada | |
| ES1070212Y (es) | Helice para embarcaciones | |
| FR2943492B3 (fr) | Tondeuse autoportee | |
| FI20090199A (fi) | Niittokone | |
| FI20095429A0 (fi) | Murskain | |
| ES1070021Y (es) | Anclaje mejorado para construccion | |
| ES1069967Y (es) | Aparato para cortar quesos | |
| ES1070104Y (es) | Tirafondo para madera |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B12B | Appeal against refusal [chapter 12.2 patent gazette] |